High Purity 4,7-Dichloroquinoline 99.5%+ for API Synthesis from Canada
Ultra-high purity 4,7-dichloroquinoline (>99.5%) specifically manufactured for active pharmaceutical ingredient synthesis, classified under HTS 2933.49.08.00 as a chemically defined quinoline derivative. Meets stringent pharma intermediate specifications.
Duty Rate — Canada → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include CoA with HPLC/GC purity data and heavy metal specifications for FDA/USDA review
• Pre-register with FDA Drug Master File if destined for US pharma production
• GMP manufacturing evidence prevents reclassification as technical grade